Advertisement
Screener

SIGHT SCIENCES, INC. (SGHT) Graph

SGHT Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $23.39M; Cost of revenue $2.01M; Research and development $2.51M; Selling, general and administrative $22.75M.
  • 2026-03-31: Revenue $19.70M; Cost of revenue $2.72M; Research and development $2.55M; Selling, general and administrative $26.84M.
  • 2025-12-31: Revenue $20.39M*; Cost of revenue $2.60M*; Research and development $2.44M*; Selling, general and administrative $19.02M*.
  • 2025-09-30: Revenue $19.91M; Cost of revenue $2.71M; Research and development $3.35M; Selling, general and administrative $21.75M.

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

SGHT revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Dry Eye$2.68MSurgical Glaucoma$20.71MRevenue$23.39MCost of revenue$2.01MGross profit$21.37MOperating expenses$25.26MOperating income-$3.89MOther income, net$82.00KResearch & development$2.51MSelling, general& administrative$22.75MPre-tax income-$4.42MIncome tax$28.00KNet income-$4.45M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$23.39M$2.01M$2.51M$22.75M$25.26M$28.00K-$4.45M
2026-03-31$19.70M$2.72M$2.55M$26.84M$29.39M$11.00K-$12.98M
2025-12-31$20.39M*$2.60M*$2.44M*$19.02M*$21.46M*$8.00K*-$4.16M*
2025-09-30$19.91M$2.71M$3.35M$21.75M$25.10M-$79.00K-$8.17M
2025-06-30$19.56M$2.98M$4.39M$23.87M$28.25M$40.00K-$11.94M
2025-03-31$17.51M$2.41M$4.43M$24.52M$28.95M$41.00K-$14.15M
2024-09-30$20.16M$3.25M$4.75M$23.39M$28.14M$166.00K-$11.07M
2024-06-30$21.37M$3.02M$4.32M$26.68M$31.00M$15.00K-$12.33M
2024-03-31$19.27M$2.79M$4.64M$26.56M$31.20M$17.00K-$16.27M
2023-09-30$20.01M$2.68M$4.24M$26.50M$30.74M$78.00K-$13.04M
2023-06-30$23.47M$3.38M$5.22M$30.06M$35.28M$8.00K-$14.75M
2023-03-31$18.82M$3.05M$4.67M$28.68M$33.34M$14.00K-$17.07M
2022-09-30$18.68M$2.93M$6.05M$31.54M$37.59M$19.00K-$22.23M
2022-06-30$17.23M$2.74M$5.93M$31.43M$37.36M$9.00K-$23.84M
2022-03-31$14.88M$3.03M$5.65M$28.39M$34.04M$9.00K-$23.26M
2021-09-30$13.10M$2.06M$4.28M$20.79M$25.07M$16.00K-$17.17M
2021-06-30$12.54M$2.31M$3.55M$17.76M$21.31M$22.00K-$17.61M
2021-03-31$8.63M$2.30M$3.44M$14.55M$17.99M$52.00K-$12.24M
2020-09-30$8.65M$2.62M$2.16M$11.23M$13.39M$8.00K-$8.10M
2020-06-30$3.50M$2.08M$1.44M$7.66M$9.11M$6.00K-$8.32M
2020-03-31(m)(m)(m)(m)(m)(m)-$9.18M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$43.09M$4.73M$5.06M$49.59M$54.65M$40.00K-$17.43M
2025-06-30$37.07M$5.39M$8.82M$48.39M$57.21M$81.00K-$26.09M
2024-06-30$40.63M$5.82M$8.95M$53.24M$62.19M$32.00K-$28.59M
2023-06-30$42.30M$6.43M$9.89M$58.73M$68.62M$22.00K-$31.82M
2022-06-30$32.11M$5.77M$11.57M$59.83M$71.40M$18.00K-$47.11M
2021-06-30$21.17M$4.61M$6.99M$32.31M$39.30M$74.00K-$29.86M
2020-06-30$10.00M$4.21M$3.84M$18.34M$22.18M$37.00K-$17.49M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$56.98M$8.10M$12.17M$70.14M$82.31M$2.00K-$34.26M
2024-09-30$60.79M$9.07M$13.70M$76.63M$90.33M$198.00K-$39.66M
2023-09-30$62.30M$9.11M$14.13M$85.23M$99.36M$100.00K-$44.86M
2022-09-30$50.79M$8.70M$17.63M$91.37M$108.99M$37.00K-$69.33M
2021-09-30$34.27M$6.67M$11.27M$53.10M$64.36M$90.00K-$47.02M
2020-09-30$18.65M$6.83M$6.00M$29.57M$35.57M$45.00K-$25.59M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$77.36M$10.70M$14.61M$89.16M$103.77M$10.00K-$38.43M
2024-12-31$79.87M$11.58M$17.99M$100.83M$118.82M$236.00K-$51.51M
2023-12-31$81.06M$11.88M$17.56M$108.89M$126.45M$110.00K-$55.55M
2022-12-31$71.33M$12.36M$22.86M$120.06M$142.92M$47.00K-$86.24M
2021-12-31$48.96M$8.61M$15.63M$76.19M$91.82M$188.00K-$62.96M
2020-12-31$27.64M$9.21M$8.87M$41.74M$50.62M$61.00K-$34.69M

Similar stocks

Stock NameCountryMarket CapPE Ratio
NeuroPace Inc (NPCE)United States$0.480B-28.52
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
CERUS CORP (CERS)United States$0.525B-86.40
CARLSMED, INC. (CARL)United States$0.405B
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
Orthofix Medical Inc. (OFIX)$0.373B
SS Innovations International, Inc. (SSII)$0.589B-64.06
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39